Home > Healthcare & Medical Devices > Hernia Mesh Devices Market
Hernia Mesh Devices Market Size is anticipated to exhibit a healthy CAGR from 2022 to 2028. These devices are used for supporting damaged tissue around hernias as they heal and are usually placed around the area surrounding the hernia, further attaching it with glue, staples, or stitches. The pores in the mesh enable the growth of tissues into the device. According to statistics, different types of hernia mesh products are utilized in almost 90% of surgeries annually in the United States.
Considering the mesh type, the biologic mesh segment is estimated to record commendable share in the overall hernia mesh devices market till 2028. The rising demand is attributed to an increase in comparative studies that are being undertaken for assessing the feasibility of biologic mesh over synthetic mesh in various procedures.
For instance, the Cleveland Clinic lately conducted a study for comparing the cost effectiveness, efficacy, and safety of biological prosthetics and synthetic mesh for the purpose of repairing ventral hernias in the setting of contaminated and clean-contaminated surgical procedures. The findings of this study are expected to have a major impact on the area of hernia surgery given that it will give an objective guide to mesh selection.
Based on the target disease, the inguinal hernia mesh segment is expected to register substantial growth during the forecast period. This is because while it is always not necessary to perform surgeries, hernias do not generally depict improvement without it. However, in some cases, if a hernia is left untreated, this can be life-threatening. This has led to an increase in the performance of numerous hernia mesh surgeries, boosting product adoption in the coming years. Common symptoms of inguinal hernia include a groin area bulge and pressure, pain, or aching at the bulge, particularly when coughing, bending, or lifting.
On the basis of region, the North America hernia mesh devices market is projected to record considerable expansion through 2028 owing to an increase in regulatory clearances for the rollout of numerous products. For instance, in August 2020, Deep Blue Medical Advances secured the clearance of the U.S. FDA for commencing the sale of its hernia mesh product. The company has recently announced its equity to USD 3.44 million.
Leading players in the hernia mesh devices market are Ethicon Endo Surgery, Hitech Equipments Company, Maquet Holding, C. R. Bard, Sutures India, Dipromed, Transeasy Medical, W.L Gore & Associates, and others. These companies are taking a keen interest in the adoption of expansion strategies including acquisitions, mergers, product developments, collaborations, and partnerships for gaining a competitive edge in the market.
For instance, in July 2021, Baxter International Inc., announced its acquisition of certain assets associated with PerClot Polysaccharide Hemostatic System from CryoLife, Inc., for a value of up to USD 60.8 million, inclusive of USD 25 million paid upfront.
The COVID-19 pandemic largely impacted the operating for non-urgent surgical pathologies, including hernias, owing to periodical cancellations of the operating lists on a global scale. According to statistics, the pandemic period recorded an increase of 18% in terms of emergency hernia surgery operating volume, with a rise of 23% of visceral resections owing to unsalvageable herniated content strangulation. Furthermore, there was hardly any increase in overall morbidity due to hernia, with no instances of postoperative mortality or the incidence of COVID-19 associated complications.
Market, by Mesh Type
Market, by Hernia Type
Market, by Surgery
Market, by Mesh Material
Market, by End-use
The above information is provided for the following regions and countries: